Hepatic Encephalopathy Management in Advanced Liver Disease

Prognostic Significance

The European Association for the Study of the Liver (EASL) guidelines indicate that recurrent or persistent hepatic encephalopathy in a patient with MELD 25-30 and GFR 28 dramatically worsens survival, with expected mortality exceeding 50% within 90 days, and this patient requires urgent liver transplantation evaluation as the only definitive treatment option 1, 2

ICU admission is indicated for MELD >20, especially with organ failures like renal dysfunction, according to the American College of Gastroenterology 3
Patients with grade 3-4 HE are at aspiration risk and require intensive monitoring, as recommended by the European Association for the Study of the Liver (EASL) 4, 5
The American Association for the Study of Liver Diseases (AASLD) recommends initiating dual therapy immediately, including lactulose and rifaximin, for patients with recurrent or persistent hepatic encephalopathy 4, 5

The 2022 EASL guidelines provide a strong recommendation (100% consensus) that patients with end-stage liver disease and recurrent or persistent HE not responding to treatments should be assessed for liver transplantation, as stated by the European Association for the Study of the Liver (EASL) 1, 2
A first episode of overt HE should prompt referral to a transplant center, and this patient has recurrent/persistent disease, according to the American Society of Transplantation 4

TIPS is contraindicated in this patient: overt recurrent/chronic HE is an absolute contraindication, and 3-month mortality with TIPS for MELD ≥25 is 66%, as reported by the Journal of Hepatology 7, 3
Benzodiazepines are absolutely contraindicated in decompensated cirrhosis, according to the American College of Gastroenterology 5

Overall survival after an episode of overt HE is only 42% at 1 year and 23% at 3 years, as reported by the Clinical and Molecular Hepatology 8

The development of HE in cirrhosis is associated with markedly reduced quality of life beyond the mortality impact, according to the European Association for the Study of the Liver (EASL) 1
Recurrent hospitalizations for HE episodes severely impair daily functioning and autonomy, as stated by the American Gastroenterological Association 5